CardioKinetix Inc. said Tuesday it has raised $44 million in a two-tranche Series E financing.
The Menlo Park-based medical device company makes implant technology to treat heart failure. It plans to use the funds to further its clinical studies and for commercialization.
No comments:
Post a Comment